NEW YORK – One Equity Partners (“OEP”), a middle market private equity firm, today announced that it has completed a strategic investment of InfuCare Rx (or “the Company”), a national provider of specialty infusion therapies and comprehensive clinical therapy management services to patients with complex conditions. Financial terms of the private transaction were not disclosed.
